-82.2%
CLSK vs GSK
+101.2%
-183.4%
-98.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.0% | -1.3% | +2.3% | +0.9% |
| 7D | -10.1% | -3.1% | -7.0% | -10.3% |
| 30D | -26.6% | -0.9% | -25.7% | -26.5% |
| 3M | -47.1% | -4.2% | -42.9% | -47.0% |
| 6M | -53.8% | -1.6% | -52.2% | -53.8% |
| YTD | -38.6% | +2.6% | -41.2% | -38.6% |
| 1Y | -42.6% | +6.2% | -48.8% | -42.6% |
| 3Y | +57.6% | +55.0% | +2.6% | +54.7% |
| 5Y | -63.8% | +42.8% | -106.6% | -65.0% |
| 10Y | -82.2% | +102.1% | -184.3% | -72.8% |
| All | -82.2% | +101.2% | -183.4% | -72.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling